Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 2/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.30 |
| ▸ | BCHE | P06276 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4728441 | 0.86 | DPP4 (0.38) | ALDH1A1POLBDPP7ATMGAA | |
| SCHEMBL22978715 | 0.75 | ALDH1A1 (0.39) | ALDH1A1POLBSMN1; SMN2HSD11B1 | |
| SCHEMBL28771501 | 0.71 | ALDH1A1 (0.41) | ALDH1A1POLBATMGAASMN1; SMN2 | |
| SCHEMBL28771185 | 0.70 | ALDH1A1 (0.44) | ALDH1A1POLBATMSMN1; SMN2HSD11B1 | |
| SCHEMBL27900748 | 0.68 | ALDH1A1 (0.42) | ALDH1A1POLBATMSMN1; SMN2HSD11B1 | |
| SCHEMBL26929345 | 0.68 | ALDH1A1 (0.42) | ALDH1A1POLBATMGAASMN1; SMN2 | |
| SCHEMBL6697255 | 0.68 | ALDH1A1 (0.50) | ALDH1A1POLBGAASMN1; SMN2HSD11B1 | |
| SCHEMBL20815558 | 0.68 | ALDH1A1 (0.35) | ALDH1A1POLBATMSMN1; SMN2 | |
| SCHEMBL18263743 | 0.68 | DPP7 (0.33) | DPP7 | |
| SCHEMBL28212548 | 0.68 | DPP7 (0.33) | DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11124693-B2 | Hydroxyalkylurethane kinetic hydrate inhibitors | INDORAMA VENTURES OXIDES LLC (US) | 2021-09-21 | — | — | US | disclosed |
| EP-3452532-B1 | SUCCINIMIDE-BASED COPOLYMERS AND USE AS HYDRATE INHIBITORS | SAUDI ARABIAN OIL CO (SA) | 2021-03-24 | — | — | EP | disclosed |
| WO-2018160306-A1 | HYDROXYALKYLURETHANE KINETIC HYDRATE INHIBITORS | HUNTSMAN PETROCHEMICAL LLC (US) | 2018-09-07 | — | — | WO | disclosed |
| US-9303201-B2 | Method of inhibiting the formation of gas hydrates using amidines and guanidines | ECO INHIBITORS AS (NO) | 2016-04-05 | — | — | US | disclosed |
| US-20140256599-A1 | METHOD OF INHIBITING THE FORMATION OF GAS HYDRATES USING AMIDINES AND GUANIDINES | ECO INHIBITORS AS (NO) | 2014-09-11 | — | — | US | disclosed |
| WO-2013053766-A1 | METHOD OF INHIBITING THE FORMATION OF GAS HYDRATES USING AMIDINES AND GUANIDINES | ECO INHIBITORS AS (NO) | 2013-04-18 | — | — | WO | disclosed |
| WO-2013053770-A1 | METHOD OF INHIBITING THE FORMATION OF GAS HYDRATES USING AMINE OXIDES | ECO INHIBITORS AS (NO) | 2013-04-18 | — | — | WO | disclosed |
| WO-2008023989-A1 | ADDITIVES FOR INHIBITING GAS HYDRATE FORMATION | UNIVERSITETET I STAVANGER (NO) | 2008-02-28 | — | — | WO | disclosed |
| EP-0828778-B1 | CLATHRATE HYDRATE INHIBITOR AND METHOD OF INHIBITING THE FORMATION OF CLATHRATE HYDRATES USING IT | NIPPON CATALYTIC CHEM IND (JP) | 2004-05-12 | — | — | EP | disclosed |
| US-6319971-B1 | CONTROLLING GAS HYDRATE FORMATION, ESPECIALLY IN PIPES AND OIL AND GAS WELLS BY USING A POLYMER MIXTURE THAT PREVENTS HYDRATE NUCLEATION; ONE POLYMER'S WEIGHT BOLTZMANN FACTOR IS HIGHER THAN THE OTHER | RF-PROCOM A/S (NO) | 2001-11-20 | — | — | US | disclosed |
| US-6232273-B1 | MACROMOLECULAR COMPOUND WITH NITROGEN-CONTAINING RING PENDANT TO THE POLYMER CHAIN, SUCH AS POLYMER OF (METH)ACRYLOYL PYRROLIDINE, PYRROLIDINOCARBONYLETHYL (METH)ACRYLATE, 2-OXO-PYRROLIDINO-ETHYL (METH)ACRYLATE, ETC. | NIPPON SHOKUBAI CO., LTD. (JP) | 2001-05-15 | — | — | US | disclosed |
| WO-1998053007-A1 | COMPOSITION FOR CONTROLLING CLATHRATE HYDRATES AND A METHOD FOR CONTROLLING CLATHRATE HYDRATE FORMATION | RF-PROCOM A/S (NO) | 1998-11-26 | — | — | WO | disclosed |
| EP-0828778-A1 | CLATHRATE HYDRATE INHIBITOR AND METHOD OF INHIBITING THE FORMATION OF CLATHRATE HYDRATES USING IT | NIPPON SHOKUBAI CO., LTD. (JP) | 1998-03-18 | — | — | EP | disclosed |
| WO-1996038492-A1 | CLATHRATE HYDRATE INHIBITOR AND METHOD OF INHIBITING THE FORMATION OF CLATHRATE HYDRATES USING IT | NIPPON SHOKUBAI CO., LTD. (JP) | 1996-12-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140256599-A1 | METHOD OF INHIBITING THE FORMATION OF GAS HYDRATES USING AMIDINES AND GUANIDINES | MAGI3, GEMIN5, GCG | ALDH1A1 3524/4885POLB 2347/4885DPP7 2240/4885 |
| US-11124693-B2 | Hydroxyalkylurethane kinetic hydrate inhibitors | HDHD5, UNG, OGG1 | ALDH1A1 462/4885POLB 43/4885DPP7 3977/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.